Key Highlights

  • agilon health (NYSE:AGL) reported a third-quarter medical services expense ratio of 88.5%, against 104.0% a year earlier, as medical services expense fell to USD 1.34 billion from USD 1.49 billion.
  • Net income was USD 34.9 million, or USD 1.97 per diluted share, compared with a net loss of USD 110.2 million, or USD 6.65 per share, after adjusting for a 1-for-25 reverse split.
  • Adjusted EBITDA, a non-GAAP measure, was USD 63.7 million versus a negative USD 91.5 million, while total Revenue rose to USD 1.52 billion from USD 1.44 billion, up 6%.
  • Medicare Advantage members fell 10% to 453,600, and attributed CMS ACO Models beneficiaries fell 3% to about 112,300, reflecting market exits and payor changes.

A 15.5 Point Drop in the Medical Expense Ratio

agilon health (NYSE:AGL) filed its Quarterly Report on November 4, 2026. The company partners with community primary care physicians, who take on the total cost of care for Medicare Advantage patients in return for monthly capitated payments. Its medical services expense ratio, medical services expense divided by medical services revenue, improved to 88.5% from 104.0%, a swing of 15.5 points (calculated). Medical services revenue grew 6% to USD 1.52 billion even as members declined, and medical services expense fell by about USD 146 million (calculated). Operating Income was USD 24.1 million compared with a loss of USD 131.3 million. For nine months, the ratio was 88.3% against 99.6%, and Net Income was USD 101.8 million.

Fewer Members, Higher Physician Incentives and Other Income

Medicare Advantage members dropped 10% to 453,600, which the company links to previously disclosed market exits and a disciplined contracting approach that led some payors to exit certain markets. Average membership was 488,000 in the quarter. Other medical expenses, which include partner physician incentive payments tied to surplus in each geography, jumped to USD 78.0 million from USD 13.5 million, a sign that better results share more profit with physician partners. General and administrative expenses rose to USD 67.1 million from USD 56.2 million. Other income, net, was USD 17.5 million, while Equity method investments swung to a USD 1.0 million loss from a USD 13.1 million gain, reflecting its ACO participation.

Cash Turns Positive, Reverse Split and Credit Facility

Nine-month Operating Cash Flow was positive at USD 16.3 million, compared with an outflow of USD 85.2 million. Cash, restricted cash and marketable securities totaled USD 311.7 million, up from USD 285.1 million at year-end. The company completed a 1-for-25 reverse split on March 30, 2026, leaving 16.8 million shares outstanding, and all per-share figures were restated. Its credit facility, extended to February 18, 2028 through an amendment, carries interest at 3.50% above SOFR for most borrowings. Management believes Liquidity is sufficient for at least 12 months. Risks include medical cost trends, payor contract exits, shrinking membership and the timing of settlements with payors. The filing contains no guidance.

Where Things Stand

Better medical cost control, not membership growth, produced the turnaround. agilon health (NYSE:AGL) cut its medical services expense ratio to 88.5% from 104.0%, moving from a USD 110.2 million loss to USD 34.9 million of net income, while membership fell 10%. Because margins now depend on keeping medical costs below capitated revenue, a Reversal in cost trends could erase the gain quickly. Watch membership trends, physician incentive payments, platform support costs and payor negotiations. No outlook is provided in the filing.